FR2634764B1 - OXAZA HETEROCYCLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

OXAZA HETEROCYCLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
FR2634764B1
FR2634764B1 FR8910300A FR8910300A FR2634764B1 FR 2634764 B1 FR2634764 B1 FR 2634764B1 FR 8910300 A FR8910300 A FR 8910300A FR 8910300 A FR8910300 A FR 8910300A FR 2634764 B1 FR2634764 B1 FR 2634764B1
Authority
FR
France
Prior art keywords
oxaza
heterocycles
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8910300A
Other languages
French (fr)
Other versions
FR2634764A1 (en
Inventor
J. Lee Sung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofor Ltd
Original Assignee
Biofor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofor Ltd filed Critical Biofor Ltd
Publication of FR2634764A1 publication Critical patent/FR2634764A1/en
Application granted granted Critical
Publication of FR2634764B1 publication Critical patent/FR2634764B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/04—Seven-membered rings having the hetero atoms in positions 1 and 2
FR8910300A 1988-08-01 1989-07-31 OXAZA HETEROCYCLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Expired - Fee Related FR2634764B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/227,572 US4892870A (en) 1988-08-01 1988-08-01 Oxaza heterocycles and pharmaceutical compositions containing same

Publications (2)

Publication Number Publication Date
FR2634764A1 FR2634764A1 (en) 1990-02-02
FR2634764B1 true FR2634764B1 (en) 1994-01-14

Family

ID=22853624

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8910300A Expired - Fee Related FR2634764B1 (en) 1988-08-01 1989-07-31 OXAZA HETEROCYCLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (9)

Country Link
US (1) US4892870A (en)
JP (1) JPH0278671A (en)
AU (1) AU3893389A (en)
BE (1) BE1002955A4 (en)
CA (1) CA1324130C (en)
DE (1) DE3925477A1 (en)
FR (1) FR2634764B1 (en)
GB (1) GB2221464B (en)
SE (1) SE504933C2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW204339B (en) * 1990-05-17 1993-04-21 Ciba Geigy Ag
AU9054291A (en) * 1990-11-26 1992-06-25 E.I. Du Pont De Nemours And Company Herbicidal oxazine ethers
US5128330A (en) * 1991-02-19 1992-07-07 Biofor, Ltd. Oxazinone substituted phosphines
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
US5215986A (en) * 1992-06-01 1993-06-01 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene oxaza heterocycles
JP3507124B2 (en) * 1993-05-26 2004-03-15 塩野義製薬株式会社 Method for producing benzylidene derivative
WO1995024398A1 (en) * 1994-03-09 1995-09-14 Pfizer Inc. Isoxazoline compounds as inhibitors of tnf release

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552585A (en) * 1984-10-04 1985-11-12 Fmc Corporation Herbicidal 2-(aminophenyl)methyl derivatives of 3-isoxazolidinones or 3-oxazinones

Also Published As

Publication number Publication date
DE3925477A1 (en) 1990-02-08
GB2221464B (en) 1992-07-08
US4892870A (en) 1990-01-09
SE8902607L (en) 1990-02-26
AU3893389A (en) 1990-02-01
CA1324130C (en) 1993-11-09
SE8902607D0 (en) 1989-07-27
GB2221464A (en) 1990-02-07
BE1002955A4 (en) 1991-10-01
FR2634764A1 (en) 1990-02-02
GB8917527D0 (en) 1989-09-13
JPH0278671A (en) 1990-03-19
SE504933C2 (en) 1997-05-26

Similar Documents

Publication Publication Date Title
FR2582513B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ALFUZOSINE
FR2612516B1 (en) BENZOXAZOLE DERIVATIVES AND PREPARATION CONTAINING THEM
FR2636532B1 (en) PHARMACEUTICAL COMPOSITIONS
DE3486441T2 (en) 3-hydroxypyrid-4-one and pharmaceutical compositions
BE892805A (en) SUBSTITUTED CYCLOALCANES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2608427B1 (en) HYDROSOLS OF PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2596758B1 (en) IMPROVED PHARMACEUTICAL SALTS OF AMLODIPINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR1100824A (en) Pharmaceutical composition and composition
DZ2086A1 (en) Substituted benzylaminopiperidines and pharmaceutical compositions containing them.
IT8721253A0 (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING COMPLEXES OF FLAVONOLIGNANS WITH PHOSPHOLIPIDS.
KR890701675A (en) Improvement of packaging and related materials
FR2626002B1 (en) DIDEOXYDIDEHYDROCARBOCYCLIC NUCLEOSIDES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2645152B1 (en) 3H-PTERIDINONES-4, METHODS OF PREPARATION AND MEDICAMENTS CONTAINING THEM
BE887970A (en) NOVEL OYTOCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES
BE888797A (en) CARNITINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
IT1239542B (en) PHARMACEUTICAL COMPOSITION INCLUDING PIROXICAM AND PROCEDURE FOR LASUA PREPARATION
FR2567510B1 (en) AMINOPHENOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2580632B1 (en) CYCLOPENTILIC ETHERS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM
FR2634764B1 (en) OXAZA HETEROCYCLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK439589D0 (en) FLUOR-SUBSTITUTED 4'-DEMETHYLEPIPODOPHYLLOTOX INGREDIENTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
FR2641276B1 (en) BENZENE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
KR900012897A (en) Guanidine derivatives and pharmaceutical compositions containing them
FR2528425B1 (en) 1,4-DIHYDROPYRIDINES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
DE68909555D1 (en) PYRIDYL KETOXIMETHER COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
FR2609392B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PYRANOQUINOLEINS

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse